These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 3877704)

  • 1. A simplified technique for quantifying 24-h whole body retention of 99mTc-labeled methylene diphosphonate (MDP).
    Castronovo FP; McKusick KA; Dann J; Prout GR; Strauss HW
    Int J Nucl Med Biol; 1985; 12(3):209-14. PubMed ID: 3877704
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A refined method for assessing 99mTc-MDP whole body retention in prostate cancer patients.
    Castronovo FP; Prout GR; Strauss HW; McKusick KA; Griffin PP
    Int J Rad Appl Instrum B; 1987; 14(5):475-7. PubMed ID: 3667311
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The 4 h/24 h 99mTc-MDP whole body retention: a new index of bone pathology.
    Castronovo FP; McKusick KA; Strauss HW
    Int J Rad Appl Instrum B; 1986; 13(6):599-602. PubMed ID: 3104238
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitative bone scintigraphy and 24-hour whole-body counting of 99mTc-methylene diphosphonate in patients with prostatic carcinoma.
    Sundkvist GM; Ahlgren L; Lilja B; Mattsson S
    Nuklearmedizin; 1992 Oct; 31(5):178-81. PubMed ID: 1465355
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Whole-body retention of 99mTc-methylene diphosphonate in skeletal diseases].
    Zorn-Bopp E; Büll U; Münzing W; Lang P; Moser EA
    Nuklearmedizin; 1983 Feb; 22(1):24-30. PubMed ID: 6223277
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Measurement of 24-hr whole-body retention of 99mTc-MDP with a thyroid uptake probe (author's transl)].
    Seto H; Kakishita M; Futatsuya R
    Radioisotopes; 1981 May; 30(5):263-7. PubMed ID: 6458840
    [TBL] [Abstract][Full Text] [Related]  

  • 7. More advantages in detecting bone and soft tissue metastases from prostate cancer using
    Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
    Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Measurement of 24 hour whole body retention of 99Tcm-diphosphonate by a single thyroid probe.
    Lang P; Büll U
    Nucl Med Commun; 1984 Oct; 5(10):627-32. PubMed ID: 6442403
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of lung metastases from osteosarcoma by scintigraphy using 99mTc-methylene diphosphonate.
    Hoefnagel CA; Bruning PF; Cohen P; Marcuse HR; van der Schoot JB
    Diagn Imaging; 1981; 50(5):277-84. PubMed ID: 6457735
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Studies on diphosphonate kinetics. Part II: Whole body bone uptake rate during constant infusion--a refined index of bone metabolism.
    Hyldstrup L; McNair P; Ring P; Henriksen O
    Eur J Nucl Med; 1987; 12(12):585-8. PubMed ID: 3107991
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Studies on 177Lu-labeled methylene diphosphonate as potential bone-seeking radiopharmaceutical for bone pain palliation.
    Abbasi IA
    Nucl Med Biol; 2011 Apr; 38(3):417-25. PubMed ID: 21492790
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparison of skeletal uptakes of three diphosphonates by whole-body retention: concise communication.
    Fogelman I; Pearson DW; Bessent RG; Tofe AJ; Francis MD
    J Nucl Med; 1981 Oct; 22(10):880-3. PubMed ID: 6457135
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantifications and sensitivity in bone scanning in the detection of bone metastases.
    Ritsema GH
    Diagn Imaging; 1982; 51(2):99-106. PubMed ID: 7075441
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Technetium-99m-methylene diphosphonate--a superior agent for skeletal imaging: comparison with other technetium complexes.
    Subramanian G; McAfee JG; Blair RJ; Kallfelz FA; Thomas FD
    J Nucl Med; 1975 Aug; 16(8):744-55. PubMed ID: 170385
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparison between the diagnostic efficacy of 99mTc-MDP, 99mTc-DPD and 99mTc-HDP for the detection of bone metastases.
    Pauwels EK; Blom J; Camps JA; Hermans J; Rijke AM
    Eur J Nucl Med; 1983; 8(3):118-22. PubMed ID: 6220908
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Whole body and regional retention of Tc-99m-labeled diphosphonates with a whole-body counter: a study with normal males.
    Molloi S; Mazess R; Bendsen H; Wilson M
    Calcif Tissue Int; 1989 May; 44(5):322-9. PubMed ID: 2496903
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of various rhenium-188-labeled diphosphonates for the treatment of bone metastases.
    Hsieh BT; Hsieh JF; Tsai SC; Lin WY; Wang SJ; Ting G
    Nucl Med Biol; 1999 Nov; 26(8):973-6. PubMed ID: 10708313
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expanded 99mTc-methylene diphosphonate (MDP) bone scan.
    Pollen JJ; Witztum K; Basarab R
    Urology; 1984 Dec; 24(6):632-8. PubMed ID: 6239440
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biokinetics of bone tracers by means of deconvolution analysis--comparison of 99mTc MDP, 99mTc DPD and 99mTc EHDP.
    Knop J; Stritzke P; Kröger E; Schneider C; Wasmus G
    Nuklearmedizin; 1982 Aug; 21(4):145-9. PubMed ID: 6216459
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Whole body retention of diphosphonate in rheumatoid arthritis.
    Steven MM; Sturrock RD; Fogelman I; Smith ML
    J Rheumatol; 1982; 9(6):873-7. PubMed ID: 7161778
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.